Plain-English translation of NCT06270667 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lymphoma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The LYMfit Study is testing whether exercise can help protect the hearts of people who have survived lymphoma. Lymphoma survivors who received certain chemotherapy drugs or radiation to the chest are at higher risk for heart problems later in life. This study compares two different types of exercise programs—aerobic exercise alone, or aerobic plus strength training—against a control group that receives standard care, to see which approach works best at improving heart fitness and preventing heart disease.
Some chemotherapy drugs and chest radiation used to treat lymphoma can damage the heart over time. Researchers want to know whether regular exercise can help prevent or reduce these heart problems in survivors, and whether combining aerobic and strength training is more effective than aerobic exercise alone.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will be randomly assigned to one of three groups: aerobic exercise twice weekly, aerobic plus strength training twice weekly, or standard care with no structured exercise. The exercise program lasts 5 months. You will complete heart fitness tests (including a treadmill test), provide a small muscle sample from your leg, have your lung function tested, and answer questions about your health and quality of life. Participants in all groups will be carefully monitored throughout the study.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Norway
Sweden